BCL2L10 and hepatocellular carcinoma: Different from the findingsevidencing Bcl2L10 as a tumor growth inhibitor in hepatocellular carcinoma[13], and inagreement with our in vitro results obtained both in this paperand in the one previously published [11], in vivo experiments demonstrated thatBcl2L10 does not affect in vivo tumor growth of M14 xenografts(Figure S2).